ML Strategies Posts Weekly Health Care Update on April 21, 2014

By Theresa C. Carnegie

ML Strategies has posted its weekly Health Care Update.  This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.

Top news this week is the continued scrutiny of drug pricing.  Between Congress, payors, and physician groups, the biopharmaceutical industry is facing significant headwinds and will be tasked with changing the value proposition (or at least articulating it differently) in order to withstand the pressure from stakeholders on cost and comparative effectiveness.

In keeping with the cost theme, the CBO released new estimates showing that the Affordable Care Act would be less costly and cover more people than previous reports.  We believe the major debate after open enrollment is now shifting to cost containment, which will be the context for many legislative and regulatory debates to come in 2014 and going forward.

Click here to read this week's Update.

 

 

Subscribe To Viewpoints

Published

Viewpoint Topics

Professionals

Author

Theresa C. Carnegie

Member

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.